OBJECTIVE: We investigated the association of the metabolic syndrome with new-onset diabetes in the Hong Kong Cardiovascular Risk Factor Prevalence Study cohort. RESEARCH DESIGN AND METHODS: We followed up on 1,679 subjects without diabetes at baseline. Those with a previous diagnosis of diabetes or those who were receiving drug treatment were considered to be diabetic. The remaining subjects underwent a 75-g oral glucose tolerance test (OGTT). Diabetes was defined by plasma glucose > or =7.0 mmol/l with fasting and/or > or =11.1 mmol/l at 2 h. RESULTS: The prevalences of the metabolic syndrome at baseline were 14.5 and 11.4%, respectively, according to U.S. National Cholesterol Education Program (NCEP) and International Diabetes Federation (IDF) criteria. After a median of 6.4 years, there were 66 and 54 new cases of diabetes in men and women, respectively. The metabolic syndrome at baseline predicted incident diabetes. Hazard ratios (HRs) for the NCEP and IDF definitions of the syndrome were 4.1 [95% CI 2.8-6.0] and 3.5 [2.3-5.2], respectively. HRs for fasting plasma glucose (FPG) > or =6.1 or 5.6 mmol/l were 6.9 [4.1-11.5] and 4.1 [2.8-6.0], respectively. The NCEP and IDF criteria had 41.9 and 31.7% sensitivity and 87.5 and 90.2% specificity, respectively. Their positive predictive values were low, approximately 20%, but their negative predictive values were approximately 95%. CONCLUSIONS: The metabolic syndrome, particularly its component, elevated FPG, predicts diabetes in Chinese. An individual without the metabolic syndrome is unlikely to develop diabetes, but one who has it should practice therapeutic lifestyle changes and have periodic FPG measurements to detect new-onset diabetes.
OBJECTIVE: We investigated the association of the metabolic syndrome with new-onset diabetes in the Hong Kong Cardiovascular Risk Factor Prevalence Study cohort. RESEARCH DESIGN AND METHODS: We followed up on 1,679 subjects without diabetes at baseline. Those with a previous diagnosis of diabetes or those who were receiving drug treatment were considered to be diabetic. The remaining subjects underwent a 75-g oral glucose tolerance test (OGTT). Diabetes was defined by plasma glucose > or =7.0 mmol/l with fasting and/or > or =11.1 mmol/l at 2 h. RESULTS: The prevalences of the metabolic syndrome at baseline were 14.5 and 11.4%, respectively, according to U.S. National Cholesterol Education Program (NCEP) and International Diabetes Federation (IDF) criteria. After a median of 6.4 years, there were 66 and 54 new cases of diabetes in men and women, respectively. The metabolic syndrome at baseline predicted incident diabetes. Hazard ratios (HRs) for the NCEP and IDF definitions of the syndrome were 4.1 [95% CI 2.8-6.0] and 3.5 [2.3-5.2], respectively. HRs for fasting plasma glucose (FPG) > or =6.1 or 5.6 mmol/l were 6.9 [4.1-11.5] and 4.1 [2.8-6.0], respectively. The NCEP and IDF criteria had 41.9 and 31.7% sensitivity and 87.5 and 90.2% specificity, respectively. Their positive predictive values were low, approximately 20%, but their negative predictive values were approximately 95%. CONCLUSIONS: The metabolic syndrome, particularly its component, elevated FPG, predicts diabetes in Chinese. An individual without the metabolic syndrome is unlikely to develop diabetes, but one who has it should practice therapeutic lifestyle changes and have periodic FPG measurements to detect new-onset diabetes.
Authors: J Zhao; Z C Pang; L Zhang; W G Gao; S J Wang; F Ning; H R Nan; J Ren; Q Qiao Journal: J Endocrinol Invest Date: 2011-01-26 Impact factor: 4.256
Authors: Chao Qiang Jiang; Bin Liu; Bernard M Y Cheung; Tai Hing Lam; Jie Ming Lin; Ya Li Jin; Xiao Jun Yue; Kwok Leung Ong; Sidney Tam; Ka Sing Wong; Brian Tomlinson; Karen S L Lam; G Neil Thomas Journal: Eur J Hum Genet Date: 2010-06-23 Impact factor: 4.246
Authors: Maarit A Laaksonen; Paul Knekt; Harri Rissanen; Tommi Härkänen; Esa Virtala; Jukka Marniemi; Arpo Aromaa; Markku Heliövaara; Antti Reunanen Journal: Eur J Epidemiol Date: 2009-12-13 Impact factor: 8.082
Authors: Claudia H T Tam; Vincent K L Lam; Wing-Yee So; Ronald C W Ma; Juliana C N Chan; Maggie C Y Ng Journal: BMC Genet Date: 2010-02-24 Impact factor: 2.797
Authors: Eman A El Bassuoni; David C Ziemer; Paul Kolm; Mary K Rhee; Viola Vaccarino; Circe W Tsui; Jack M Kaufman; G Eileen Osinski; David D Koch; K M Venkat Narayan; William S Weintraub; Lawrence S Phillips Journal: Prim Care Diabetes Date: 2008-06-11 Impact factor: 2.459
Authors: Wing Sun Chow; Annette Wai Kwan Tso; Aimin Xu; Michele Mae Ann Yuen; Carol Ho Yi Fong; Tai Hing Lam; Su Vui Lo; Hung Fat Tse; Yu Cho Woo; Chun Yip Yeung; Bernard Man Yung Cheung; Karen Siu Ling Lam Journal: J Am Heart Assoc Date: 2013-01-15 Impact factor: 5.501